AstraZeneca-Oxford Vaccine Up To 90% Effective At Preventing Covid-19, Early Results Show

  • 📰 Forbes
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 53%

United States Headlines News

United States Latest News,United States Headlines

I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter @theroberthart or email me at rhart@forbes.com

Findings from Oxford University and AstraZeneca's clinical Covid-19 vaccine trial show it to be, onInterim analysis of the Phase 3 clinical trial — which involved over 24,000 participants — showed the vaccine to be 70% effective with no severe side effects, though this was based on data from two different dosing regimens tested.

Looked at individually, the vaccine, which requires two separate injections about a month apart, was 90% effective when given at a lower dose and 62% effective when given at a higher dose. the “findings show that we have an effective vaccine that will save many lives,” adding that more people could be vaccinated with the same supply if the more effective lower dosing regimen is used.

The vaccine is a hope to many around the world, for it is cheaper and easier to store than other promising candidates from Moderna and Pfizer and it requires only a standard refrigerator and ordinary distribution channels.. AstraZeneca has commitments to supply 3 billion doses of the vaccine in 2021, which could vaccinate more than 1.5 billion people, and is already undertaking large-scale manufacturing in anticipation of regulatory approval. that “today marks an important milestone in our fight against the pandemic” and that the vaccine will “have an immediate impact” on the Covid-19 crisis.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

What a joke

FDA authorizes restart of the COVID-19 AZD1222 vaccine US Phase III trial via AstraZeneca

........ up to...... sooo. Not even close

A range from 62 to 90 per cent. Still just an interim analysis.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca-Oxford Vaccine Up To 90% Effective At Preventing Covid-19, Early Results ShowI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com Who would have thought thank you very much for your work
Source: Forbes - 🏆 394. / 53 Read more »

AstraZeneca, Oxford say their vaccine is up to 90% effective“We are delighted with these results, the efficacy level is very high,” Professor Adrian Hill, Director of the Jenner Institute, tells ABC News as AstraZeneca and University of Oxford say their COVID-19 vaccine is up to 90% effective. We Chinese all know COVID-19 was intentional accidentally leaked on Sept 18, 2019 when CCP did a drill to plant & detect the virus at Wuhan airport. The virus was made in a PLA lab - The other side of the pandemic the mainstream media doesn’t want you to know. Knowing the truth brings Happiness Sureeeeee
Source: ABC - 🏆 471. / 51 Read more »

AstraZeneca, Oxford University say their COVID-19 vaccine is up to 90% effectiveAstraZeneca and Oxford University say their COVID-19 vaccine is up to 90% effective in preventing the disease in late-stage trials. People of the world. I'm asking for help, my son Artem needs urgent heart surgery. He has a heart defect. There's less and less time left. If you can help, go to my profile information there. I beg you on your knees, help save your son Honestly, with the way that US pharma companies fudge the numbers by being hyperspecific in the people they select for trials, an Oxford 70% is probably a US 90%. That's what they will give to low income areas umm.
Source: latimes - 🏆 11. / 82 Read more »

Here’s What You Need To Know About AstraZeneca’s Covid-19 VaccineAstraZeneca, with partner Oxford University, released preliminary data for its phase 3 Covid-19 Monday showing that the vaccine may be up to 90% effective. Again, we ask for the evidence that this vaccine works on ALL strains of covid and in all circumstances before we will recommend this to any of our clients! Why is the pharma industry hiding this evidence? Here’s what you need to know HELL NO LOL
Source: Forbes - 🏆 394. / 53 Read more »

AstraZeneca study finds its COVID-19 vaccine effective, with one regimen showing 90% efficacyAstraZeneca undefinedundefined said its COVID-19 vaccine candidate met its primary endpoint showing protection from COVID-19 occurring 14 days or more after receiving two doses of the vaccine. One dosing regimen showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart, and another dosing regimen showed 62% efficacy when given as two full doses at least one month apart. No serious safety events related to the vaccine have been confirmed. AstraZeneca will now immediately prepare regulatory submission of the data to authorities around the world that have a framework in place for conditional or early approval. 90% of news about covid and trump I literally said something about AstraZeneca and their vaccine. Thanks for listening y’all, now shove that needle in my arm! SPX 4K by year end!
Source: MarketWatch - 🏆 3. / 97 Read more »